Related Experiment Videos
Association of Presepsis Statin Prescription With Kidney and Mortality Outcomes: Cause-Specific, Overlap-Weighted
Min Woo Kang1, Soojeong Yun1, Seung Min Song1
1Department of Internal Medicine, Korea University Guro Hospital, Seoul, Republic of Korea.
Rationale & Objective:
Sepsis, complicated by kidney injury, poses a mortality risk in intensive care unit patients. Although statins are thought to offer protective effects against kidney injury through anti-inflammatory mechanisms, evidence remains inconclusive. This study aimed to evaluate whether statin prescription before sepsis onset affects the risks of kidney injury and mortality.
Study Design:
Retrospective cohort study.
Setting & Participants:
Adult intensive care unit patients who met Sepsis-3 criteria in Medical Information Mart for Intensive Care-IV.
Exposure:
Statin prescription within the 24 hours preceding sepsis onset.
Outcomes:
The primary outcome was the prespecified kidney outcome (need for kidney replacement therapy or a reduction in estimated glomerular filtration rate of ≥50%). Secondary outcomes were mortality without the kidney outcome (cause-specific) and overall mortality.
Analytical Approach:
We used overlap weighting to balance baseline characteristics. Cause-specific Cox models estimated associations for the kidney outcome and mortality without the kidney outcome; a weighted Cox model estimated associations for overall mortality.
Results:
The final cohort included 30,765 patients with sepsis, with 19.3% exposed to statins. Statin prescription was associated with a reduced risk of kidney outcome (HR, 0.83; 95% CI, 0.80-0.87), mortality without kidney outcome (HR, 0.56; 95% CI, 0.51-0.63), and overall mortality (HR, 0.78; 95% CI, 0.71-0.84). Subgroup analyses were broadly consistent across prespecified strata. For the kidney outcome, interaction testing suggested greater risk reduction among patients aged <65 years, those without chronic kidney disease, and those with hypertension. For death without prior kidney outcome and for overall mortality, protective associations were consistent across subgroups, with a larger effect among patients with prior myocardial infarction. Overall, statin prescription was consistently associated with lower risks of kidney outcome and mortality.
Limitations:
Single-database retrospective design and incomplete capture of sepsis severity measures.
Conclusions:
Presepsis statin prescription was associated with lower risks of kidney outcome and mortality, indicating potential clinical benefits in patients with sepsis.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Drug toxicity: Drug–Drug Interaction
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Pharmacokinetics: Drug–Drug Interactions
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration